VC-backed BIND Therapeutics raises $70.5 mln in IPO

BIND Therapeutics, a biopharmaceutical company with venture backing, raised $70.5 million before underwriting discounts and commissions in its initial public offering of 4,700,000 shares priced at $15 per share.

DealsNorth AmericaUSBriefs